These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

162 related items for PubMed ID: 1697369

  • 1. Kinin- and non-kinin-mediated interactions of converting enzyme inhibitors with vasoactive hormones.
    Kramer HJ, Glänzer K, Meyer-Lehnert H, Mohaupt M, Predel HG.
    J Cardiovasc Pharmacol; 1990; 15 Suppl 6():S91-8. PubMed ID: 1697369
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Converting enzyme inhibitors and the interaction between kinins and eicosanoids.
    Schrör K.
    J Cardiovasc Pharmacol; 1990; 15 Suppl 6():S60-8. PubMed ID: 1697363
    [Abstract] [Full Text] [Related]

  • 5. [Do kinins have significance for the antihypertensive effect of angiotensin-converting enzyme inhibitors?].
    Bönner G.
    Z Kardiol; 1988; 77 Suppl 3():23-7. PubMed ID: 3062958
    [Abstract] [Full Text] [Related]

  • 6. Hypotensive and natriuretic effects of RB 105, a new dual inhibitor of angiotensin converting enzyme and neutral endopeptidase in hypertensive rats.
    Gonzalez Vera W, Fournié-Zaluski MC, Pham I, Laboulandine I, Roques BP, Michel JB.
    J Pharmacol Exp Ther; 1995 Jan; 272(1):343-51. PubMed ID: 7815350
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Angiotensin-converting enzyme inhibition in patients with essential hypertension.
    Kramer HJ, Predel HG, Meyer-Lehnert H.
    Clin Physiol Biochem; 1990 Jan; 8 Suppl 1():16-24. PubMed ID: 2257720
    [Abstract] [Full Text] [Related]

  • 9. Systemic and renal effects of atrial natriuretic peptide in patients with heart failure treated with angiotensin-converting enzyme inhibitor or in acute saline solution loading.
    Tomiyama H, Watanabe G, Abe M, Okazaki R, Yoshida H, Doba N.
    Am Heart J; 2001 Mar; 141(3):422-7. PubMed ID: 11231440
    [Abstract] [Full Text] [Related]

  • 10. Determinants of in vivo activity of neutral endopeptidase 3.4.24.11 and angiotensin converting enzyme inhibitors.
    Seymour AA, Asaad MM, Abboa-Offei BE, Smith PL, Rogers WL, Dorso CR.
    J Pharmacol Exp Ther; 1996 Feb; 276(2):708-13. PubMed ID: 8632340
    [Abstract] [Full Text] [Related]

  • 11. Effects of captopril and enalapril on sodium excretion and blood pressure in sodium-deficient dogs.
    McCaa RE, Gillespie JB.
    Fed Proc; 1984 Apr; 43(5):1336-41. PubMed ID: 6323226
    [Abstract] [Full Text] [Related]

  • 12. [Effect of atrial natriuretic peptide (ANP) on the renal kallikrein-kinin system in normotensive and spontaneously hypertensive rats].
    Bönner G, Hirzel B, Ganten D, Kaufmann W.
    Z Kardiol; 1988 Apr; 77 Suppl 2():85-91. PubMed ID: 2841816
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Natriuretic action of ANP is blunted by ACE inhibition in humans.
    Wambach G, Schittenhelm U, Stimpel M, Bönner G, Kaufmann W.
    J Cardiovasc Pharmacol; 1989 May; 13(5):748-53. PubMed ID: 2472523
    [Abstract] [Full Text] [Related]

  • 17. Antihypertensive and natriuretic effects of CGS 30440, a dual inhibitor of angiotensin-converting enzyme and neutral endopeptidase 24.11.
    Chatelain RE, Ghai RD, Trapani AJ, Odorico LM, Dardik BN, De Lombaert S, Lappe RW, Fink CA.
    J Pharmacol Exp Ther; 1998 Mar; 284(3):974-82. PubMed ID: 9495857
    [Abstract] [Full Text] [Related]

  • 18. Suppression of choroidal neovascularization by inhibiting angiotensin-converting enzyme: minimal role of bradykinin.
    Nagai N, Oike Y, Izumi-Nagai K, Koto T, Satofuka S, Shinoda H, Noda K, Ozawa Y, Inoue M, Tsubota K, Ishida S.
    Invest Ophthalmol Vis Sci; 2007 May; 48(5):2321-6. PubMed ID: 17460297
    [Abstract] [Full Text] [Related]

  • 19. Role of prostaglandins in the cardiovascular effects of bradykinin and angiotensin-converting enzyme inhibitors.
    Schrör K.
    J Cardiovasc Pharmacol; 1992 May; 20 Suppl 9():S68-73. PubMed ID: 1282633
    [Abstract] [Full Text] [Related]

  • 20. Renal effects of angiotensin II receptor blockade and angiotensin-converting enzyme inhibition in healthy subjects.
    Burnier M, Brunner HR.
    Exp Nephrol; 1996 May; 4 Suppl 1():41-6. PubMed ID: 9001896
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.